Key facts
- Patients Know Best’s last known valuation is $49.5M (Sep 2025).
- It has raised $46.2M.
- Notable investors include Seedcamp, Caffeinated Capital, Elad Gil, Claret Capital Partners, Esther Dyson — 28 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 28 names
- ·Watchlist + deal alerts for Patients Know Best
- ·The full record, as it builds
Funding rounds
No funding rounds for Patients Know Best are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Patients Know Best
Developer of a software-as-a-service platform designed to store health information in a single place. The company's platform collects data from healthcare providers and shares it with patients, carers, and care teams with immediate access to vital information like appointment letters, care plans, medication lists, test results, allergies and details of previous attendances and discharge summaries, enabling patients to take control of their health and physicians to increase the efficiency of communication.
- Sector
- Healthcare
- HQ
- Cambridge, United Kingdom
- Founded
- 2008
- Employees
- 93
- Website
- patientsknowbest.com/
- Ownership
- Privately Held (backing)
Patients Know Best doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Patients Know Best shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Patients Know Best in its N-PORT filings yet. We sweep new filings monthly.